DK1663141T3 - Vandig farmaceutisk oplösning indeholdende oxymetazolin og/eller xylometazolin - Google Patents

Vandig farmaceutisk oplösning indeholdende oxymetazolin og/eller xylometazolin

Info

Publication number
DK1663141T3
DK1663141T3 DK04740995T DK04740995T DK1663141T3 DK 1663141 T3 DK1663141 T3 DK 1663141T3 DK 04740995 T DK04740995 T DK 04740995T DK 04740995 T DK04740995 T DK 04740995T DK 1663141 T3 DK1663141 T3 DK 1663141T3
Authority
DK
Denmark
Prior art keywords
xylometazoline
solution containing
aqueous pharmaceutical
pharmaceutical solution
oxymetazoline
Prior art date
Application number
DK04740995T
Other languages
Danish (da)
English (en)
Inventor
Frank Boehme
Bernd Eschenbach
Dagmar Faerber
Claudia Hey
Barbara Pfaff
Marion Tschaikin
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34201503&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1663141(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK1663141T3 publication Critical patent/DK1663141T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK04740995T 2003-08-13 2004-07-14 Vandig farmaceutisk oplösning indeholdende oxymetazolin og/eller xylometazolin DK1663141T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10337186A DE10337186A1 (de) 2003-08-13 2003-08-13 Wässrige Wirkstoff-Lösung
PCT/EP2004/007780 WO2005018601A1 (de) 2003-08-13 2004-07-14 Wässrige phramateuziche lösung enthaltend oxymetazolin und/oder xylometazolin

Publications (1)

Publication Number Publication Date
DK1663141T3 true DK1663141T3 (da) 2007-07-30

Family

ID=34201503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04740995T DK1663141T3 (da) 2003-08-13 2004-07-14 Vandig farmaceutisk oplösning indeholdende oxymetazolin og/eller xylometazolin

Country Status (19)

Country Link
US (1) US20060222718A1 (pt)
EP (1) EP1663141B1 (pt)
JP (1) JP4750703B2 (pt)
KR (1) KR20060065677A (pt)
CN (1) CN100531733C (pt)
AT (1) ATE357212T1 (pt)
AU (1) AU2004266443A1 (pt)
BR (1) BRPI0413478A (pt)
CA (1) CA2535533C (pt)
CY (1) CY1107633T1 (pt)
DE (2) DE10337186A1 (pt)
DK (1) DK1663141T3 (pt)
ES (1) ES2282871T3 (pt)
MX (1) MXPA06001596A (pt)
PL (1) PL1663141T3 (pt)
PT (1) PT1663141E (pt)
RU (1) RU2343918C2 (pt)
WO (1) WO2005018601A1 (pt)
ZA (1) ZA200602071B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005075735A (ja) * 2003-08-28 2005-03-24 Rohto Pharmaceut Co Ltd オキシメタゾリン含有組成物
DE102007052380A1 (de) † 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
CN101576539B (zh) * 2009-06-19 2012-05-23 广东省药品检验所 一种盐酸赛洛唑啉中杂质a的测定方法
US20120225918A1 (en) * 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
DE102012005452A1 (de) * 2011-12-30 2013-07-04 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die nasale Applikation mit verbesserter Stabilität
US10598672B2 (en) 2014-02-18 2020-03-24 Cyrano Therapeutics, Inc. Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
US20170348230A1 (en) 2014-12-24 2017-12-07 Jadran-Galenski Laboratorij D.D A nasal composition containing sea water as stability-improving excipient
BR112018072177A2 (pt) * 2016-05-17 2019-02-12 Proponent Biotech Gmbh composição farmacêutica, recipiente, e, métodos para tratar e prevenir congestão nasal, infecções virais do trato respiratório e/ou inflamação da garganta
DE202017104738U1 (de) 2017-07-31 2018-08-01 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue Zusammensetzung für die nasale Applikation
CN107362141B (zh) * 2017-08-16 2018-06-05 深圳大佛药业股份有限公司 一种盐酸羟甲唑啉鼻喷雾剂及其制备方法
US20210244710A1 (en) * 2018-07-02 2021-08-12 Kangping Xiao Stable pharmaceutical formulations of oxymetazoline
US10814001B1 (en) 2019-05-06 2020-10-27 Rvl Pharmaceuticals, Inc. Oxymetazoline compositions
JP7606530B2 (ja) 2020-03-24 2024-12-25 シラノ セラピューティクス， インコーポレイテッド コロナウイルス感染症による化学感覚機能障害の治療
WO2023046590A1 (en) 2021-09-22 2023-03-30 Jadran - Galenski Laboratorij D.D. An improved pharmaceutical composition for nasal use, preparation, and use thereof
CN117982422B (zh) * 2024-04-03 2024-07-26 深圳大佛药业股份有限公司 一种用于治疗鼻炎的喷雾剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478565A (en) * 1990-03-27 1995-12-26 Warner-Lambert Company Treatment of sinus headache
DE19549421C2 (de) * 1995-11-10 1999-11-18 Klosterfrau Mcm Vetrieb Gmbh Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden
CA2311530C (en) * 1998-01-30 2008-06-10 Novartis Consumer Health S.A. Nasal solutions
JPH11302184A (ja) * 1998-04-21 1999-11-02 Taisho Pharmaceut Co Ltd 点鼻用組成物
NL1011016C2 (nl) * 1999-01-13 2000-07-14 Dagra Pharma Bv Neusspray op basis van xylometazoline en kamille-extract.
AU765736B2 (en) * 1999-06-22 2003-09-25 Boehringer Ingelheim International Gmbh Stable xylometazoline and oxymetazoline solution
EP1328214A4 (en) * 2000-09-20 2009-07-29 Shahinian Lee Jr NASAL, INHALABLE AND LOCAL OPHTHALMIC PREPARATIONS AND MEDICATIONS WITH SPONTANEOUS CONSERVATION
RU2212235C1 (ru) * 2001-12-24 2003-09-20 Закрытое акционерное общество "Брынцалов-А" Капли назальные бризолин, обладающие сосудосуживающим, противовоспалительным и противоотечным действием

Also Published As

Publication number Publication date
AU2004266443A1 (en) 2005-03-03
JP4750703B2 (ja) 2011-08-17
ATE357212T1 (de) 2007-04-15
RU2006107446A (ru) 2007-09-20
CN100531733C (zh) 2009-08-26
WO2005018601A1 (de) 2005-03-03
PT1663141E (pt) 2007-06-27
ZA200602071B (en) 2007-05-30
BRPI0413478A (pt) 2006-10-17
EP1663141A1 (de) 2006-06-07
JP2007501817A (ja) 2007-02-01
MXPA06001596A (es) 2006-05-19
RU2343918C2 (ru) 2009-01-20
CA2535533A1 (en) 2005-03-03
KR20060065677A (ko) 2006-06-14
CY1107633T1 (el) 2013-03-13
DE10337186A1 (de) 2005-03-17
PL1663141T3 (pl) 2007-07-31
EP1663141B1 (de) 2007-03-21
DE502004003305D1 (de) 2007-05-03
US20060222718A1 (en) 2006-10-05
CN1832726A (zh) 2006-09-13
CA2535533C (en) 2011-10-18
ES2282871T3 (es) 2007-10-16

Similar Documents

Publication Publication Date Title
DK1663141T3 (da) Vandig farmaceutisk oplösning indeholdende oxymetazolin og/eller xylometazolin
NO20054018L (no) Intranasal formulering av rotigotin
CU23367A3 (es) Formulación de moxifloxacino con sal común
HN1999000183A (es) Preparado farmaceuticos de moxifloxacina
DK1475101T3 (da) Antistof-holdige farmaceutiske opløsninger
CY1106468T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
ATE408601T1 (de) Fredericamycin-derivate
AR035266A1 (es) Solucion desinfectante basada en hipoclorito sodico y procedimiento para su preparacion
GEP20084340B (en) Pharmaceutical compositions comprising fentanyl for intranasal delivery
PT1556371E (pt) Derivados de benzimidazole e sua utilizacao como pro-farmacos de inibadores da bomba de protoes.
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
EA201070194A1 (ru) Стабильная жидкая фармацевтическая композиция на основе тразодона
EA200870546A1 (ru) Стабильные водные суспензии
NO20070250L (no) S-Tenatoprazol-natriummonohydratsalt og dennes anvendelse i form av en protonpumpe-inhibitor
AU2001285944A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
NO20044769L (no) Behandling av smerte med ifendropil
NO20055882L (no) Farmasoytiske formuleringer omfattende amoksicillin og klavulanat
ATE528003T1 (de) Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen
NO20050163L (no) Mikrokapsler for den forsinkede og kontrollerte frigivelse av perindopril
RU2003117898A (ru) Способ местного лечения деструктивных форм неспецифических заболеваний легких, плевритов и эмпием плевральной полости
SE0401942D0 (sv) New antimicrobial peptide complexes
NO20050781L (no) Cefalosporiner
RU2000105080A (ru) Препарат для лечения гриппа
RU2007116719A (ru) НОВОЕ ПРИМЕНЕНИЕ ДЛЯ α-СИМПАТОМИМЕТИКОВ, ИМЕЮЩИХ 2-ИМИДАЗОЛИНОВУЮ СТРУКТУРУ